| Drug Name: | idarucizumab |
|---|
| Drug Class: | Anticoagulant reversal agent |
|---|
| Mechanism of Action: | Binds to and neutralizes the anticoagulant effects of dabigatran, a direct thrombin inhibitor |
|---|
| Use: | - Reversal of dabigatran-induced anticoagulation in emergency situations
- Perioperative management of dabigatran-treated patients requiring urgent surgery or invasive procedures
|
|---|
| Side Effects: | - Headache
- Hypotension
- Nausea
- Vomiting
|
|---|
| Contraindications: | - Hypersensitivity to idarucizumab or any component of the formulation
|
|---|
| Specialty: | - Emergency Medicine
- Critical Care
- Cardiology
- Hematology
|
|---|